BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34985594)

  • 1. AM22, a novel synthetic microRNA, inhibits the proliferation of colorectal cancer cells by targeting core binding factor subunit β (CBFB).
    Meng F; Li J; Qiu Y; Zhang H; Zhang H; Wang W
    Invest New Drugs; 2022 Jun; 40(3):469-477. PubMed ID: 34985594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-145 regulates osteoblastic differentiation by targeting the transcription factor Cbfb.
    Fukuda T; Ochi H; Sunamura S; Haiden A; Bando W; Inose H; Okawa A; Asou Y; Takeda S
    FEBS Lett; 2015 Oct; 589(21):3302-8. PubMed ID: 26450370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular RNA_0062582 promotes osteogenic differentiation of human bone marrow mesenchymal stem cells via regulation of microRNA-145/CBFB axis.
    Li F; Wu H; Zou G; Cang D; Shen Y
    Bioengineered; 2021 Dec; 12(1):1952-1963. PubMed ID: 34027799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant inhibition of B7-H3 and PD-L1 expression by a novel and synthetic microRNA delivers potent antitumor activities in colorectal tumor models.
    Meng F; Chen Y; Yang M; Zhang H; Wang W
    Invest New Drugs; 2021 Oct; 39(5):1267-1274. PubMed ID: 33909231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circular RNA circ-CBFB promotes proliferation and inhibits apoptosis in chronic lymphocytic leukemia through regulating miR-607/FZD3/Wnt/β-catenin pathway.
    Xia L; Wu L; Bao J; Li Q; Chen X; Xia H; Xia R
    Biochem Biophys Res Commun; 2018 Sep; 503(1):385-390. PubMed ID: 29902450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long Noncoding RNA LINC01234 Functions as a Competing Endogenous RNA to Regulate CBFB Expression by Sponging miR-204-5p in Gastric Cancer.
    Chen X; Chen Z; Yu S; Nie F; Yan S; Ma P; Chen Q; Wei C; Fu H; Xu T; Ren S; Sun M; Wang Z
    Clin Cancer Res; 2018 Apr; 24(8):2002-2014. PubMed ID: 29386218
    [No Abstract]   [Full Text] [Related]  

  • 7. CBFB cooperates with p53 to maintain TAp73 expression and suppress breast cancer.
    Malik N; Yan H; Yang HH; Ayaz G; DuBois W; Tseng YC; Kim YI; Jiang S; Liu C; Lee M; Huang J
    PLoS Genet; 2021 May; 17(5):e1009553. PubMed ID: 33945523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of MDM4 Gene Regulation by miR-34a on LOVO Cell Proliferation.
    Li S; Pei Y; Zhang W; Sun L; Jiang M; Shang G; Niu S; Ma Z
    Ann Clin Lab Sci; 2020 May; 50(3):342-347. PubMed ID: 32581023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A promising effect of zerumbone with improved anti-tumor-promoting inflammation activity of miR-34a in colorectal cancer cell lines.
    Dehghan R; Najafi R; Azizi Jalilian F; Saidijam M; Radaei Z; Zamani A; Ezati R; Asna-Ashari F; Amini R
    Mol Biol Rep; 2021 Jan; 48(1):203-218. PubMed ID: 33398678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of HMGB1 by miR-34a is sufficient to suppress proliferation, migration and invasion of human cervical and colorectal cancer cells.
    Chandrasekaran KS; Sathyanarayanan A; Karunagaran D
    Tumour Biol; 2016 Oct; 37(10):13155-13166. PubMed ID: 27456356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA.
    Wang Y; Tang Q; Li M; Jiang S; Wang X
    Biochem Biophys Res Commun; 2014 Feb; 444(2):199-204. PubMed ID: 24440701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-Associated Exosomal CBFB Facilitates the Aggressive Phenotype, Evasion of Oxidative Stress, and Preferential Predisposition to Bone Prometastatic Factor of Breast Cancer Progression.
    Hsu CH; Ma HP; Ong JR; Hsieh MS; Yadav VK; Yeh CT; Chao TY; Lee WH; Huang WC; Kuo KT; Fong IH; Lin CC; Su CM
    Dis Markers; 2022; 2022():8446629. PubMed ID: 35903297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circular RNA 100146 Promotes Colorectal Cancer Progression by the MicroRNA 149/HMGA2 Axis.
    Liu K; Mou Y; Shi X; Liu T; Chen Z; Zuo X
    Mol Cell Biol; 2021 Jan; 41(2):. PubMed ID: 33257506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-34a targets FMNL2 and E2F5 and suppresses the progression of colorectal cancer.
    Lu G; Sun Y; An S; Xin S; Ren X; Zhang D; Wu P; Liao W; Ding Y; Liang L
    Exp Mol Pathol; 2015 Aug; 99(1):173-9. PubMed ID: 26103003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-141-3p inhibits cell proliferation, migration and invasion by targeting TRAF5 in colorectal cancer.
    Liang Z; Li X; Liu S; Li C; Wang X; Xing J
    Biochem Biophys Res Commun; 2019 Jun; 514(3):699-705. PubMed ID: 31078266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
    Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
    Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNA-200b and microRNA-200c promote colorectal cancer cell proliferation via targeting the reversion-inducing cysteine-rich protein with Kazal motifs.
    Pan Y; Liang H; Chen W; Zhang H; Wang N; Wang F; Zhang S; Liu Y; Zhao C; Yan X; Zhang J; Zhang CY; Gu H; Zen K; Chen X
    RNA Biol; 2015; 12(3):276-89. PubMed ID: 25826661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The p53/miR-145a Axis Promotes Cellular Senescence and Inhibits Osteogenic Differentiation by Targeting Cbfb in Mesenchymal Stem Cells.
    Xia C; Jiang T; Wang Y; Chen X; Hu Y; Gao Y
    Front Endocrinol (Lausanne); 2020; 11():609186. PubMed ID: 33505358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Evidence for Curcumin and Boswellic Acid-Induced Chemoprevention through Regulation of miR-34a and miR-27a in Colorectal Cancer.
    Toden S; Okugawa Y; Buhrmann C; Nattamai D; Anguiano E; Baldwin N; Shakibaei M; Boland CR; Goel A
    Cancer Prev Res (Phila); 2015 May; 8(5):431-43. PubMed ID: 25712055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-100 regulates SW620 colorectal cancer cell proliferation and invasion by targeting RAP1B.
    Peng H; Luo J; Hao H; Hu J; Xie SK; Ren D; Rao B
    Oncol Rep; 2014 May; 31(5):2055-62. PubMed ID: 24626817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.